Evotec SE shares rise 1.90% intraday after publishing Articles of Association.

Evotec SE rose 1.90% in intraday trading, with the company's recent update on its Articles of Association. The update outlines the company's name, registered office, and its primary focus on research activities in biologically functional synthetic, semi-synthetic, and natural active agents, as well as their development, manufacture, and sales.